Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, February 08, 2010

Northwest Biotherapeutics Inc. - press release

"The Company is also conducting a Phase I/II trial with DCVax(R) for recurrent metastatic ovarian cancer."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.